146 related articles for article (PubMed ID: 14534938)
1. [Preventative biology of type 1 diabetes: implications for clinical preventative studies].
Gorus FK; Weets I; Decochez K; van der Auwera BJ
Verh K Acad Geneeskd Belg; 2003; 65(4):203-29; discussion 229-31. PubMed ID: 14534938
[TBL] [Abstract][Full Text] [Related]
2. The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus.
Gorus FK
Verh K Acad Geneeskd Belg; 1996; 58(5):539-86. PubMed ID: 9008403
[TBL] [Abstract][Full Text] [Related]
3. Identification of prediabetes in first-degree relatives at intermediate risk of type I diabetes.
Truyen I; De Grijse J; Weets I; Kaufman L; Pipeleers L; Nanos N; Decochez K; Hilbrands R; Kaufman JM; Keymeulen B; Mathieu C; Van Gaal L; Pipeleers DG; Gorus FK;
Clin Exp Immunol; 2007 Aug; 149(2):243-50. PubMed ID: 17521324
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
[TBL] [Abstract][Full Text] [Related]
5. [Type 1 diabetes: origin and possibilities for prevention].
Mathieu C; Decallonne B; Casteels K
Verh K Acad Geneeskd Belg; 2000; 62(5):423-36; discussion 436-7. PubMed ID: 11144689
[TBL] [Abstract][Full Text] [Related]
6. [Early diagnosis and prevention of type 1 diabetes: role of the Belgian Diabetes Registry].
Weets I; Truyen I; Philips JC; Gorus F
Rev Med Liege; 2005; 60(5-6):306-12. PubMed ID: 16035286
[TBL] [Abstract][Full Text] [Related]
7. Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.
Keymeulen B
Verh K Acad Geneeskd Belg; 2008; 70(2):85-103. PubMed ID: 18630722
[TBL] [Abstract][Full Text] [Related]
8. Prediction and diagnosis of type 1 diabetes using beta-cell autoantibodies.
Batstra MR; Aanstoot HJ; Herbrink P
Clin Lab; 2001; 47(9-10):497-507. PubMed ID: 11596913
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in type 1 diabetes.
Taplin CE; Barker JM
Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
[TBL] [Abstract][Full Text] [Related]
10. [Screening, prediction and prevention of type 1 diabetes. Role of the Belgian Diabetes Registry].
Dorchy H
Rev Med Brux; 1999 Feb; 20(1):15-20. PubMed ID: 10091531
[TBL] [Abstract][Full Text] [Related]
11. Study of islet cell antibodies as predictive marker of type 1 diabetes.
Mitrea MC; Cojocaru M
Rom J Intern Med; 1998; 36(3-4):261-5. PubMed ID: 10822523
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of islet cell antibodies among 1021 relatives of type 1 diabetics].
Maiz A; Manrique M; Hodgson MI; Díaz de Valdés M; Acosta AM; Andrade L; Olmos P
Rev Med Chil; 1999 May; 127(5):515-22. PubMed ID: 10451620
[TBL] [Abstract][Full Text] [Related]
13. [Cost benefit of screening for type 1 diabetes. A futuristic scenario].
Lévy-Marchal C
Diabete Metab; 1993 Dec; 19(5 Suppl):538-45. PubMed ID: 8206195
[TBL] [Abstract][Full Text] [Related]
14. [Immune markers of type-I diabetes mellitus in children with diabetes in their first-degree relatives. Part I].
Buczkowska EO; Chobot PJ
Przegl Lek; 2003; 60(9):580-4. PubMed ID: 15065337
[TBL] [Abstract][Full Text] [Related]
15. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
Aly TA; Ide A; Humphrey K; Barker JM; Steck A; Erlich HA; Yu L; Miao D; Redondo MJ; McFann K; Roberts CM; Babu SR; Norris JM; Eisenbarth GS; Rewers MJ
J Autoimmun; 2005; 25 Suppl():40-5. PubMed ID: 16242305
[TBL] [Abstract][Full Text] [Related]
16. Strategies for preventing type I diabetes mellitus.
Verge CF; Eisenbarth GS
West J Med; 1996 Mar; 164(3):249-55. PubMed ID: 8775937
[TBL] [Abstract][Full Text] [Related]
17. [Is prevention of type I diabetes mellitus feasible?].
Thivolet C
Diabete Metab; 1994; 20(2 Pt 2):235-9. PubMed ID: 8001710
[TBL] [Abstract][Full Text] [Related]
18. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics, beta-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with Type 1 diabetes without pancreatic autoantibodies.
Aguilera E; Casamitjana R; Ercilla G; Oriola J; Nicoletti F; Gomis R; Conget I
Diabet Med; 2005 Feb; 22(2):137-43. PubMed ID: 15660729
[TBL] [Abstract][Full Text] [Related]
20. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
Franke B; Galloway TS; Wilkin TJ
Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
